The European Commission has conditionally approved the marketing application submitted by Ipsen for Iqirvo (elafibranor) 80mg ...
On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...
A US biotech that discovers new therapeutics by harnessing the most powerful force in the fight against disease: natural human immunity. Augmenta uses advanced automation, microfluidics, high ...